NINAU1

CAT # Inoa Huahana wehewehe
CPD100608 ASK1-Inhibitor-10 ʻO ka ASK1 Inhibitor 10 he mea hoʻopaneʻe waha bioavailable o ka apoptosis hōʻailona-hoʻoponopono kinase 1 (ASK1). He koho ia no ASK1 ma luna o ASK2 a me MEKK1, TAK-1, IKKβ, ERK1, JNK1, p38α, GSK3β, PKCθ, a me B-RAF. Kāohi ia i ka piʻi ʻana o ka streptozotocin-induced i ka JNK a me ka p38 phosphorylation i loko o INS-1 pancreatic β cell ma kahi ʻano hilinaʻi.
CPD100607 K811 ʻO K811 kahi mea hoʻopaneʻe kikoʻī ASK1 e hoʻolōʻihi i ke ola ʻana i kahi ʻano ʻiole o ka amyotrophic lateral sclerosis. Kāohi maikaʻi ʻo K811 i ka hoʻonui ʻana o ke kelepona ma nā laina kelepona me ka hōʻike ASK1 kiʻekiʻe a ma nā pūnaewele GC-overexpressing HER2. ʻO ka lapaʻau ʻana me K811 i hoʻemi ʻia ka nui o nā maʻi maʻi xenograft ma o ka hoʻohaʻahaʻa ʻana i nā hōʻailona proliferation.
CPD100606 K812 ʻO K812 kahi mea hoʻopaneʻe kikoʻī ASK1 i ʻike ʻia e hoʻolōʻihi i ke ola ʻana i kahi ʻano ʻiole o ka amyotrophic lateral sclerosis.
CPD100605 MSC-2032964A ʻO MSC 2032964A kahi mea hoʻokae ASK1 ikaika a koho (IC50 = 93 nM). Hoʻopaʻa ia i ka LPS-induced ASK1 a me ka p38 phosphorylation i nā astrocytes ʻiole moʻomeheu a hoʻopau i ka neuroinflammation i kahi kiʻi EAE kiʻi. ʻO MSC 2032964A ka mea hiki ke loaʻa i ka waha a me ka lolo.
CPD100604 Selonsertib ʻO Selonsertib, ka mea i kapa ʻia ʻo GS-4997, he mea hoʻopiʻi waha bioavailable o ka apoptosis signal-regulating kinase 1 (ASK1), me nā hana anti-inflammatory, antineoplastic a me nā hana anti-fibrotic. ʻO GS-4997 nā pahuhopu a hoʻopaʻa i ka catalytic kinase domain o ASK1 ma kahi ʻano hoʻokūkū ATP, no laila e pale ai i kāna phosphorylation a me ka hoʻāla ʻana. Kāohi ʻo GS-4997 i ka hana ʻana o nā cytokine inflammatory, hoʻoponopono i ka hōʻike ʻana o nā genes i komo i ka fibrosis, hoʻopau i ka apoptosis nui a keʻakeʻa i ka hoʻonui ʻana o ka cellular proliferation.
,

Kāhea iā mā˚ou

Ninau

Nuhou Hou

  • ʻO 7 ʻoi loa ma ka noiʻi lāʻau lapaʻau ma 2018

    ʻO 7 ʻoi loa i ka noiʻi lāʻau lapaʻau I...

    Ma lalo o ka piʻi nui ʻana o ka hoʻokūkū e hoʻokūkū i kahi ʻenehana paʻakikī a me ka ʻenehana, pono e hoʻomau nā ʻoihana lāʻau lapaʻau a me biotech i kā lākou papahana R&D e noho i mua ...

  • ARS-1620: He mea hoʻohiki hou no nā maʻi maʻi KRAS-mutant

    ARS-1620: He mea hoʻohiki hou no K...

    Wahi a kahi noiʻi i paʻi ʻia ma Cell, ua hoʻomohala nā mea noiʻi i kahi inhibitor kūikawā no KRASG12C i kapa ʻia ʻo ARS-1602 i hoʻoulu i ka regression tumor i nā ʻiole. "Ke hāʻawi nei kēia haʻawina i nā hōʻike vivo e hiki ke lilo i mutant KRAS ...

  • Loaʻa iā AstraZeneca ka hoʻoikaika kānāwai no nā lāʻau lapaʻau oncology

    Loaʻa iā AstraZeneca ka hoʻonui hoʻoponopono no...

    Ua loaʻa iā AstraZeneca kahi hoʻonui pālua no kāna kōpili oncology i ka Pōʻalua, ma hope o ka ʻae ʻana o nā regulators US a me ʻEulopa i nā hoʻouna kānāwai no kāna mau lāʻau lapaʻau, ʻo ka hana mua i ka lanakila ʻana i kēia mau lāʻau lapaʻau. ...

WhatsApp kamaʻilio pūnaewele!